Bibliographic citations
Rios, T., (2024). Efectividad de propionato de fluticasona comparado con bromuro de ipratropio para mejorar la severidad de síntomas en rinitis senil [Tesis, Universidad Privada Antenor Orrego]. https://hdl.handle.net/20.500.12759/33411
Rios, T., Efectividad de propionato de fluticasona comparado con bromuro de ipratropio para mejorar la severidad de síntomas en rinitis senil [Tesis]. PE: Universidad Privada Antenor Orrego; 2024. https://hdl.handle.net/20.500.12759/33411
@misc{renati/374257,
title = "Efectividad de propionato de fluticasona comparado con bromuro de ipratropio para mejorar la severidad de síntomas en rinitis senil",
author = "Rios Quiroz, Thalia Marisol",
publisher = "Universidad Privada Antenor Orrego",
year = "2024"
}
Determine if ipratropium bromide is more effective than fluticasone propionate in reducing the severity of symptoms in patients diagnosed with senile rhinitis. Materials and methods: This prospective cohort study, where patients diagnosed with senile rhinitis were treated with ipratropium bromide or fluticasone propionate, with a total of 66 patients divided into both groups, reevaluated after a month and showing a reduction in symptoms, taking place at the Regional Teaching Hospital of Trujillo during May to October 2023. Results: It was evidenced that fluticasone propionate was more effective for congestion than ipratropium bromide with 60.6% (20), being ineffective with ipratropium bromide with a (p = 0.218), while the symptoms of rhinorrhea and sneezing were effectively reduced by ipratropium bromide with (p < 0.001) and (p < 0.013) respectively. These patients had an average age of 72.5 with an SD ± 6.2, an average BMI of 25.97 with an SD ± 5.61. Furthermore, it was evident that the majority were women, with 62.1% (41). Conclusions: Ipratropium bromide was more effective than fluticasone propionate in reducing symptoms of rhinorrhea and sneezing.
This item is licensed under a Creative Commons License